Hee-Kwon Park - JoVE Visualize

Showing results (41-50 of 50) with videos related to

Pageof 5

Sort By:

You have reached the last page of results.This site can display upto 50 results.

Brain Research|October 9, 2007

Systemic transplantation of human adipose stem cells attenuated cerebral inflammation and degeneration in a hemorrhagic stroke modelJeong-Min Kim, Soon-Tae Lee, Kon Chu, et al.

Journal of Stroke|April 10, 2023

Moderate-Intensity Rosuvastatin Plus Ezetimibe Versus High-Intensity Rosuvastatin for Target Low-Density Lipoprotein Cholesterol Goal Achievement in Patients With Recent Ischemic Stroke: A Randomized Controlled TrialKeun-Sik Hong, Oh Young Bang, Jong-Ho Park, et al.

Scientific Reports|July 2, 2026

Association of cytochrome P450 2C19 genotypes with effectiveness of clopidogrel in ischemic stroke by smoking statusHyungjong Park, Hye Sun Lee, Yo Han Jung, et al.

American Heart Journal|March 9, 2026

Design and Rationale of the Clinical trial to obtain the highest efficacy of dual antiplatelet therapy after carotid artery stenting in high bleeding risk patients (CHET): a multicenter, randomized, open-label, superiority trialHyung Jun Kim, Tae-Jin Song, Moo-Seok Park, et al.

Contemporary Clinical Trials|November 27, 2025

Comparison of clopidogrel-based antiplatelet therapy versus warfarin as a secondary prevention strategy for AntiPhospholipid Syndrome-related STROKE (APS-STROKE): Rationale and design of a prospective, randomized, open-label, blinded-endpoint trialWookjin Yang, Hee-Kwon Park, Seong-Ho Koh, et al.

JAMA Network Open|January 28, 2025

Nelonemdaz and Patients With Acute Ischemic Stroke and Mechanical Reperfusion: The RODIN Randomized Clinical TrialJin Soo Lee, Hyun Goo Kang, Seong Hwan Ahn, et al.

Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|August 27, 2025

Exploring the efficacy and safety of dual antiplatelet therapy in patients with embolic stroke of undetermined source according to stroke risk stratification: Propensity-score matched analysisHyung Jun Kim, Woo-Keun Seo, Jong-Won Chung, et al.

Journal of the American Heart Association|November 12, 2025

Supracardiac Atherosclerotic Lesions in Embolic Stroke of Undetermined Source: Predicting Stroke Recurrence and Enhancing Secondary Prevention StrategiesHyung Jun Kim, Hyun Kyung Kim, Jang-Hyun Baek, et al.

Journal of Stroke|October 14, 2025

Atrial Cardiopathy Worsens Neurological Severity, Raises Recurrence Rates, and Leads to Poor Vascular Outcomes in Patients With Embolic Stroke of Undetermined SourceSung Hun Kim, Hyung Jun Kim, Hyun Kyung Kim, et al.

Journal of the American Heart Association|April 28, 2026

SVO70 (Optimal Target Low-Density Lipoprotein Cholesterol Level for Small Vessel Occlusion Stroke): Rationale and Study DesignWookjin Yang, Tae-Jin Song, Seong-Ho Koh, et al.

Pageof 5

Showing results (41-50 of 50) with videos related to

Sort By:

Pageof 5

You have reached the last page of results.This site can display upto 50 results.

Brain Research|October 9, 2007

Systemic transplantation of human adipose stem cells attenuated cerebral inflammation and degeneration in a hemorrhagic stroke modelJeong-Min Kim, Soon-Tae Lee, Kon Chu, et al.

Journal of Stroke|April 10, 2023

Moderate-Intensity Rosuvastatin Plus Ezetimibe Versus High-Intensity Rosuvastatin for Target Low-Density Lipoprotein Cholesterol Goal Achievement in Patients With Recent Ischemic Stroke: A Randomized Controlled TrialKeun-Sik Hong, Oh Young Bang, Jong-Ho Park, et al.

Scientific Reports|July 2, 2026

Association of cytochrome P450 2C19 genotypes with effectiveness of clopidogrel in ischemic stroke by smoking statusHyungjong Park, Hye Sun Lee, Yo Han Jung, et al.

American Heart Journal|March 9, 2026

Design and Rationale of the Clinical trial to obtain the highest efficacy of dual antiplatelet therapy after carotid artery stenting in high bleeding risk patients (CHET): a multicenter, randomized, open-label, superiority trialHyung Jun Kim, Tae-Jin Song, Moo-Seok Park, et al.

Contemporary Clinical Trials|November 27, 2025

Comparison of clopidogrel-based antiplatelet therapy versus warfarin as a secondary prevention strategy for AntiPhospholipid Syndrome-related STROKE (APS-STROKE): Rationale and design of a prospective, randomized, open-label, blinded-endpoint trialWookjin Yang, Hee-Kwon Park, Seong-Ho Koh, et al.

JAMA Network Open|January 28, 2025

Nelonemdaz and Patients With Acute Ischemic Stroke and Mechanical Reperfusion: The RODIN Randomized Clinical TrialJin Soo Lee, Hyun Goo Kang, Seong Hwan Ahn, et al.

Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|August 27, 2025

Exploring the efficacy and safety of dual antiplatelet therapy in patients with embolic stroke of undetermined source according to stroke risk stratification: Propensity-score matched analysisHyung Jun Kim, Woo-Keun Seo, Jong-Won Chung, et al.

Journal of the American Heart Association|November 12, 2025

Supracardiac Atherosclerotic Lesions in Embolic Stroke of Undetermined Source: Predicting Stroke Recurrence and Enhancing Secondary Prevention StrategiesHyung Jun Kim, Hyun Kyung Kim, Jang-Hyun Baek, et al.

Journal of Stroke|October 14, 2025

Atrial Cardiopathy Worsens Neurological Severity, Raises Recurrence Rates, and Leads to Poor Vascular Outcomes in Patients With Embolic Stroke of Undetermined SourceSung Hun Kim, Hyung Jun Kim, Hyun Kyung Kim, et al.

Journal of the American Heart Association|April 28, 2026

SVO70 (Optimal Target Low-Density Lipoprotein Cholesterol Level for Small Vessel Occlusion Stroke): Rationale and Study DesignWookjin Yang, Tae-Jin Song, Seong-Ho Koh, et al.

Pageof 5